Literature DB >> 30165588

ESC Council on hypertension position document on the management of hypertensive emergencies.

Bert-Jan H van den Born1, Gregory Y H Lip2,3, Jana Brguljan-Hitij4, Antoine Cremer5, Julian Segura6, Enrique Morales6, Felix Mahfoud7, Fouad Amraoui1, Alexandre Persu8, Thomas Kahan9, Enrico Agabiti Rosei10, Giovanni de Simone11, Philippe Gosse5, Bryan Williams12.   

Abstract

Hypertensive emergencies are those situations where very high blood pressure (BP) values are associated with acute organ damage, and therefore, require immediate, but careful, BP reduction. The type of acute organ damage is the principal determinant of: (i) the drug of choice, (ii) the target BP, and (iii) the timeframe in which BP should be lowered. Key target organs are the heart, retina, brain, kidneys, and large arteries. Patients who lack acute hypertension-mediated end organ damage do not have a hypertensive emergency and can usually be treated with oral BP-lowering agents and usually discharged after a brief period of observation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30165588     DOI: 10.1093/ehjcvp/pvy032

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


  25 in total

Review 1.  Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2021-05-05       Impact factor: 28.314

2.  Association of Dipstick Proteinuria with Long-Term Mortality among Patients with Hypertensive Crisis in the Emergency Department.

Authors:  Byung Sik Kim; Mi-Yeon Yu; Jin-Kyu Park; Jinho Shin; Jeong-Hun Shin
Journal:  J Pers Med       Date:  2022-06-14

3.  Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.

Authors:  Joerg Herrmann; Daniel Lenihan; Saro Armenian; Ana Barac; Anne Blaes; Daniela Cardinale; Joseph Carver; Susan Dent; Bonnie Ky; Alexander R Lyon; Teresa López-Fernández; Michael G Fradley; Sarju Ganatra; Giuseppe Curigliano; Joshua D Mitchell; Giorgio Minotti; Ninian N Lang; Jennifer E Liu; Tomas G Neilan; Anju Nohria; Rupal O'Quinn; Iskra Pusic; Charles Porter; Kerry L Reynolds; Kathryn J Ruddy; Paaladinesh Thavendiranathan; Peter Valent
Journal:  Eur Heart J       Date:  2022-01-31       Impact factor: 35.855

4.  Too Aggressive Drop in Blood Pressure in a Hypertensive Male Leading to "Man-in-the-Barrel Syndrome".

Authors:  Chamara Dalugama; Achila Jayasinghe; Udaya Ralapanawa; Shamali Abeygunawardena; Thilak Jayalath
Journal:  Case Rep Neurol Med       Date:  2020-09-24

Review 5.  Hypertension Urgencies and Emergencies: The GEAR Project.

Authors:  Massimo Salvetti; Fabio Bertacchini; Giovanni Saccà; Maria Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-21

6.  Clinical value of multiorgan damage in hypertensive crises: A prospective follow-up study.

Authors:  Hongkun Ma; Mengdi Jiang; Zongjie Fu; Zhiyu Wang; Pingyan Shen; Hao Shi; Xiaobei Feng; Yongxi Chen; Xiaoyi Ding; Zhiyuan Wu; Wen Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

Review 7.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

8.  The Total Antioxidant Status, Serum Selenium Concentrations and the Ultrasound Assessment Carotid Intima Media Thickness in Patients with Arterial Hypertension.

Authors:  Paweł Gać; Małgorzata Poręba; Lidia Januszewska; Adam Prokopowicz; Helena Martynowicz; Grzegorz Mazur; Rafał Poręba
Journal:  Antioxidants (Basel)       Date:  2021-01-06

9.  Malignant hypertension: does this still exist?

Authors:  Magdalena Domek; Jakub Gumprecht; Gregory Y H Lip; Alena Shantsila
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

Review 10.  [European guidelines for the management of arterial hypertension 2018-what has changed?]

Authors:  S Jung; R E Schmieder
Journal:  Internist (Berl)       Date:  2019-02       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.